Barrington Research upgraded Haemonetics (NYSE: HAE) from Market Perform to Outperform.

For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.

Shares of Haemonetics closed at $38.10 yesterday.